Literature DB >> 8950556

Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection.

Q He1, K Edelman, H Arvilommi, J Mertsola.   

Abstract

An outbreak of parapertussis was studied prospectively in 38 first and second grade pupils of an elementary school. Eleven (29%) children were confirmed to be culture positive for Bordetella parapertussis. Serum samples were collected from 31 children for assay of antibodies to filamentous hemagglutinin (FHA), pertactin (PRN), and pertussis toxin of Bordetella pertussis. At the first sampling, ten children were found to have a cough and 21 were asymptomatic. Of the latter, 12 remained asymptomatic and eight developed cough within 11 to 53 days (mean +/- standard deviation, 31 +/- 12 days) after sampling. One child was identified as culture positive for Bordetella pertussis and, thus, not included in the analysis of Bordetella parapertussis infection. The mean levels of IgC antibodies to FHA and PRN were significantly higher in the 12 asymptomatic children than in the eight children who later developed cough or in 20 healthy control children of the same age (for FHA, p = 0.009 and < 0.001, respectively; for PRN, p = 0.002 and 0.002, respectively). These preliminary data suggest that Bordetella parapertussis infection is more prevalent than documented, and that children with high levels of IgG antibodies to FHA and PRN can remain asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950556     DOI: 10.1007/bf01701521

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

Authors:  B Aricò; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

2.  Erythromycin for treatment and prevention of pertussis.

Authors:  J W Bass
Journal:  Pediatr Infect Dis       Date:  1986 Jan-Feb

3.  P.70 pertactin, an outer-membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli.

Authors:  L J Li; G Dougan; P Novotny; I G Charles
Journal:  Mol Microbiol       Date:  1991-02       Impact factor: 3.501

4.  Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland.

Authors:  J Mertsola
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Frequency of unrecognized Bordetella pertussis infections in adults.

Authors:  J G Deville; J D Cherry; P D Christenson; E Pineda; C T Leach; T L Kuhls; S Viker
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

6.  Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house.

Authors:  S Iwata; T Aoyama; A Goto; H Iwai; Y Sato; H Akita; Y Murase; T Oikawa; T Iwata; S Kusano
Journal:  Dev Biol Stand       Date:  1991

7.  Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.

Authors:  R W Steketee; S G Wassilak; W N Adkins; D G Burstyn; C R Manclark; J Berg; D Hopfensperger; W L Schell; J P Davis
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

8.  Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.

Authors:  N Khelef; B Danve; M J Quentin-Millet; N Guiso
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  A placebo-controlled trial of a pertussis-toxoid vaccine.

Authors:  B Trollfors; J Taranger; T Lagergård; L Lind; V Sundh; G Zackrisson; C U Lowe; W Blackwelder; J B Robbins
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

10.  Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis.

Authors:  Q He; J Mertsola; J P Himanen; O Ruuskanen; M K Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

View more
  4 in total

1.  Outcomes of Bordetella infections in vaccinated children: effects of bacterial number in the nasopharynx and patient age.

Authors:  Q He; H Arvilommi; M K Viljanen; J Mertsola
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

Authors:  M Watanabe; M Nagai
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.

Authors:  Pauline Versteegen; Alex-Mikael Barkoff; Marta Valente Pinto; Jan van de Kasteele; Aapo Knuutila; Sagida Bibi; Lia de Rond; Johanna Teräsjärvi; Katherine Sanders; Mary-Lène de Zeeuw-Brouwer; Raakel Luoto; Hinke Ten Hulscher; Elizabeth A Clutterbuck; Elisabeth A M Sanders; Jussi Mertsola; Guy A M Berbers; Qiushui He; Dominic F Kelly; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

4.  Bordetella parapertussis outbreak in Bisham, Pakistan in 2009-2010: fallout of the 9/11 syndrome.

Authors:  S Javed; F Said; S A M A S Eqani; H Bokhari
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.